Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Top Holding

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Jan 09, 2018 7:47am

96 Views

Post# 27311370

Top Holding

Although he didn't speak about NPC on yesterday's Market Call, was interested to see that it's the top holding in his fund. Either he can't find any current use for the money or he's still hanging in there waiting for a better offer. GLTA

FUND PROFILE
Aventine Canadian Equity Fund
Performance as of: December 31, 2017

1 Month: 2.6% fund, 1.2% index
1 Year: 17% fund, 9.1% index
3 Year: 11.8% fund, 6.6% index

*Index: S&P/TSX Composite Total Return
**Net of fees, dividends reinvested

TOP HOLDINGS AND WEIGHTINGS